Quantinuum Inc. (QNT), a Broomfield, Colorado-based full-stack quantum computing company formed from the combination of Honeywell's quantum business and Cambridge Quantum, jumped sharply on Friday. Shares rose more than 25%, climbing to about $37.28 from a previous close of $29.82, adding roughly $7.46. The earnings-driven move marked a decisive reversal from the prior session's nearly 9% slide, as investors rewarded a strong third-quarter report, a raised revenue outlook, and a surge in new bookings.
The dominant driver was Quantinuum's third-quarter results, released after Thursday's close. The company reported an adjusted loss of $0.29 per share, narrower than the roughly $0.37 loss Wall Street had modeled, while revenue rose 233% year over year to $9.1 million, topping consensus estimates near $8.1 million. Management also raised its full-year 2026 revenue outlook to a range of $31 million to $34 million, up from $28 million to $32 million, and reiterated expectations for more than 100% revenue growth in 2027 off the higher base.
Beyond the headline figures, the market focused on a dramatic acceleration in demand. Third-quarter bookings reached $98 million, compared with just $4.3 million in the second quarter, lifting year-to-date bookings to roughly $104 million with full-year bookings now expected to exceed $120 million. The quarter included the largest cloud agreement in company history with a global financial institution, a new hyperscaler partnership, an Oracle hybrid-computing beta program, and new work with a top-five pharmaceutical company and GE Vernova. On the technology front, the Helios system achieved a record 99.9995% logical fidelity, and the company said its Sol and Apollo systems remain on schedule for 2027 and 2029.
Quantinuum's move was reinforced by a broader rally across quantum computing names. IONQ also reported better-than-expected quarterly results, and the sector traded higher as investors grew more confident that the technology is progressing from experimentation toward commercial deployment. Analyst commentary was supportive: JPMorgan maintained an overweight rating and raised estimates on stronger bookings, while Jefferies cited Quantinuum's expanding technical lead. Honeywell (HON), which holds a majority stake, adds industrial credibility to the story.
The rally arrived after a punishing stretch. Quantinuum shares had fallen roughly 51% in 2026 and slipped about 9% in the prior session amid a broader technology-sector rout, leaving the stock trading near its 52-week low of $28.31. Trading volume has been well above average around the report, reflecting intense investor repositioning. The rebound lifted the stock off its lows and back toward levels last seen weeks ago, though it remains far below the $60 IPO price and the 50-day moving average, underscoring how much ground the stock still has to recover.
The near-term focus will be on whether the booking pipeline converts into recognized revenue and whether the company can sustain its technical roadmap. Investors will track progress on Sol's commercial availability in the second half of 2027 and Apollo's 2029 delivery, along with monetization details of the new cloud partnerships. Risks remain: adjusted EBITDA losses widened to $80.5 million as research and development spending scaled, and cash declined to roughly $1.94 billion, keeping execution and cash burn in the spotlight. The company's substantial balance sheet provides a cushion, but the path to profitability remains long and lumpy.
For traders seeking a systematic approach to fast-moving stocks like Quantinuum, Tickeron offers hundreds of AI trading bots covering thousands of tickers. Only the strongest performers under current market conditions are featured in its curated Trending AI Robots section. Bots vary by strategy, timeframe, performance metrics, and traded symbols, allowing users to filter for approaches that match their goals. Explore the page to see which automated strategies are currently leading the market.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Oscillator for QNT moved out of oversold territory on November 03, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 1 similar instances when the indicator left oversold territory. In 1 of the 1 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +5.82% 3-day Advance, the price is estimated to grow further. Considering data from situations where QNT advanced for three days, in 9 of 9 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
QNT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on QNT as a result. In 4 of 4 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for QNT turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 2 similar instances when the indicator turned negative. In 2 of the 2 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where QNT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for QNT entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 19 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.834) is normal, around the industry mean (-2.526). P/E Ratio (-21.750) is within average values for comparable stocks, (15.160). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.069) among similar stocks. P/S Ratio (81.967) is also within normal values, averaging (70.854).
The Tickeron Price Growth Rating for this company is 78 (best 1 - 100 worst), indicating slightly worse than average price growth. QNT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QNT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry PackagedSoftware